Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Triton in connection with the acquisition of Prenax
Mandate

Vinge advises Triton in connection with the acquisition of Prenax

July 01, 2025 M&A Contentious Regulatory Banking and Finance Commercial Agreements Employment and Benefits IT, Telecommunications and Outsourcing Data protection and processing of personal data Intellectual Property Real Estate and Construction

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.

Prenax is a leading subscriptions management service provider. The company was founded in 1993 and today manages the administration of over 340,000 subscriptions on behalf of its clients. Prenax has offices in 11 countries across the UK & Benelux, the Nordics, Southern Europe, the US, and Australia. 

The transaction is subject to regulatory approvals.

Vinge’s team mainly consisted of Johanna Wiberg, Egil Svensson, Michella Lina Said and Hedvig Merkel (M&A), David Olander and Lovisa Arpi (Regulatory), August Ahlin (Banking and Finance), Mario Saad and Jacob Eberil (Agreements), William Karo Persson (Employment), Carla Håkansson (IT), Siri Blomberg (GDPR), Arvid Axelryd and Melinda Oldenburg (IP), Simon Gille-Johnson (Real Estate), Hayaat Ibrahim (Compliance), Diana Kanold (Transaction Support Coordinator).

Read the client’s press release.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026